Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-Cell Lymphoma (DLBCL)

Explore clinical trials studying Diffuse Large B-Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

47 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-Cell Lymphoma (DLBCL) trial results

Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

NCT02445248

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • UCSF Medical Center . San Francisco, California, United States
  • Emory University School of Medicine/Winship Cancer Institute SC CTL019 Atlanta, Georgia, United States
  • University of Chicago Medical Center Hematology and Oncology SC - CTL019B2207J Chicago, Illinois, United States
  • University of Kansas Cancer Center SC - CTL019C2201 Westwood, Kansas, United States
View all 26 locations
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13

NCT00400478

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Follicular NHL Grade 3b, Hemic and Lymphatic Diseases, +10 more
Locations
  • Border Medical Oncology Wodonga, Victoria, Australia
  • Concord Repatriation General Hospital Concord, Australia
  • Gosford Hospital Gosford, Australia
  • Greenslopes Hospital Greenslopes, Australia
View all 131 locations
View Trial Details

Related conditions